InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Conway Charles, Directeur Scientifique. Director active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 4 reports have been logged. History available since 23 November 2021. The latest transaction was disclosed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
3,750 shares0Common SharesSEC:0001562180-22-000355
3,750 shares0Common SharesSEC:0001562180-22-000355:0
◇
10,000 shares@ US$37.540.025% mcap50.0% of flowCommon SharesSEC:0001562180-21-007297:0
◇
10,000 shares@ US$37.540.025% mcap100.0% of flowCommon SharesSEC:0001562180-21-007297
4 of 4 declarations
About Conway Charles
Charles Conway is the Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Biohaven.
